Ashland Inc. (ASH)
NYSE: ASH ยท Real-Time Price ยท USD
72.40
-1.72 (-2.32%)
Nov 20, 2026, 4:00 PM EST - Market closed
Ashland Financials Overview
Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Sep '26 Sep 30, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 |
Revenue Revenue Growth | 1,863 | 1,863 | 1,824 | 2,113 | 2,191 | 2,391 |
Revenue Growth | 2.14% | 2.14% | -13.68% | -3.56% | -8.37% | 13.26% |
Gross Profit Gross Profit Growth | 601 | 601 | 612 | 685 | 668 | 830 |
Operating Income Operating Income Growth | 113 | 113 | 168 | 171 | 166 | 310 |
Net Income Net Income Growth | 4 | 4 | -845 | 169 | 178 | 927 |
Earnings Per Share EPS Growth | 0.09 | 0.09 | -18.37 | 3.35 | 3.32 | 16.52 |
EPS Growth | - | - | - | 1.05% | -79.93% | 360.14% |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Sep '26 Sep 30, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 |
Life Sciences Life Sciences Growth | 671 | 671 | 641 | 810 | 869 | 815 |
Personal Care Personal Care Growth | 591 | 592 | 577 | 634 | 598 | 678 |
Specialty Additives Specialty Additives Growth | 503 | 504 | 511 | 572 | 600 | 719 |
Intermediates Intermediates Growth | 136 | 135 | 137 | 144 | 185 | 256 |
Eliminations Eliminations Growth | -38 | -39 | -42 | -47 | -61 | -77 |
Other Other Growth | 1,863 | 1,863 | 0 | 0 | 0 | 0 |
Revenue (Total) Revenue (Total) Growth | 3,726 | 3,726 | 1,824 | 2,113 | 2,191 | 2,391 |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Sep '26 Sep 30, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 |
Cash & Investments Cash & Investments Growth | 480 | 480 | 215 | 300 | 417 | 646 |
Total Debt Total Debt Growth | 1,472 | 1,472 | 1,490 | 1,468 | 1,458 | 1,383 |
Net Cash (Debt) Net Cash Growth | -992 | -992 | -1,275 | -1,168 | -1,041 | -737 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -21.57 | -21.57 | -27.72 | -23.36 | -19.28 | -13.16 |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Sep '26 Sep 30, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 339 | 339 | 94 | 411 | 243 | -213 |
Capital Expenditures CapEx Growth | -88 | -88 | -98 | -137 | -170 | -113 |
Free Cash Flow Free Cash Flow Growth | 251 | 251 | -4 | 274 | 73 | -326 |
Free Cash Flow Growth | - | - | - | 275.34% | - | - |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Sep '26 Sep 30, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 |
Gross Margin | 32.26% | 32.26% | 33.55% | 32.42% | 30.49% | 34.71% |
Operating Margin | 6.07% | 6.07% | 9.21% | 8.09% | 7.58% | 12.96% |
Pretax Margin | 3.70% | 3.70% | -44.35% | -1.14% | 7.30% | 8.62% |
Profit Margin | 0.21% | 0.21% | -46.33% | 8.00% | 8.12% | 38.77% |
FCF Margin | 13.47% | 13.47% | -0.22% | 12.97% | 3.33% | -13.63% |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 22, 2026 | Sep '26 Sep 30, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 |
Dividend Per Share Dividend Per Share Growth | 1.680 | - | 1.640 | 1.580 | 1.440 | 1.270 |
Dividend Per Share Growth | 1.52% | - | 3.80% | 9.72% | 13.39% | 10.44% |
Dividend Yield | 2.32% | - | 3.45% | 1.75% | 1.75% | 1.41% |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 22, 2026 | Sep '26 Sep 30, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 |
PE Ratio | 832.61 | 777.57 | - | 25.13 | 23.51 | 5.55 |
Forward PE | 17.00 | 16.57 | 11.06 | 16.40 | 16.03 | 16.41 |
P/FCF Ratio | 13.22 | 12.39 | - | 15.50 | 57.33 | - |
PS Ratio | 1.78 | 1.67 | 1.20 | 2.01 | 1.91 | 2.15 |